نتائج البحث - "Nardone A."

1

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

المساهمون: Sethunath, Vidyalakshmi, Hu, Huizhong, DE ANGELIS, Carmine, Veeraraghavan, Jamunarani, Qin, Lanfang, Wang, Nichola, Simon, Lukas M, Wang, Tao, Fu, Xiaoyong, Nardone, Agostina, Pereira, Resel, Nanda, Sarmistha, Griffith, Obi L, Tsimelzon, Anna, Shaw, Chad, Chamness, Gary C, Reis-Filho, Jorge S, Weigelt, Britta, Heiser, Laura M, Hilsenbeck, Susan G, Huang, Shixia, Rimawi, Mothaffar F, Gray, Joe W, Osborne, C Kent, Schiff, Rachel

المصدر: Mol Cancer Res
Mol. Cancer Res. 17, 2318-2330 (2019)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Geranylgeranyl pyrophosphate, Receptor, ErbB-2, Farnesyl pyrophosphate, Mevalonic Acid, Antineoplastic Agents, Apoptosis, Breast Neoplasms, Mechanistic Target of Rapamycin Complex 1, Lapatinib, Article, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Cell Line, Tumor, Survivin, Humans, Medicine, Phosphorylation, skin and connective tissue diseases, neoplasms, Molecular Biology, business.industry, Cell growth, Trastuzumab, 030104 developmental biology, Oncology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, Female, Mevalonate pathway, Growth inhibition, business, Signal Transduction, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47e32d952d195af7dec86930048dfc3Test
https://doi.org/10.1158/1541-7786.mcr-19-0756Test

2

Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade

المؤلفون: Valerio Nardone, Rocco Giannicola, Giovanna Bianco, Diana Giannarelli, Paolo Tini, Pierpaolo Pastina, Antonia Consuelo Falzea, Sebastiano Macheda, Michele Caraglia, Amalia Luce, Silvia Zappavigna, Luciano Mutti, Luigi Pirtoli, Antonio Giordano, Pierpaolo Correale

المساهمون: Nardone, V., Giannicola, R., Bianco, G., Giannarelli, D., Tini, P., Pastina, P., Falzea, A. C., Macheda, S., Caraglia, M., Luce, A., Zappavigna, S., Mutti, L., Pirtoli, L., Giordano, A., Correale, P.

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, Durvalumab, Salvage therapy, Pembrolizumab, Gastroenterology, Procalcitonin, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, prognostic factors of response, medicine, cell death receptor, Lung cancer, programmed cell death ligand-1, RC254-282, Original Research, business.industry, bacterial infection, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, inflammatory markers, inflammatory marker, real-world salvage therapy, bacterial infections, immune-check point blockade, procalcitonin, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbc2d28bc8b055476a3a290898f44b4Test
https://pubmed.ncbi.nlm.nih.gov/34195086Test

3

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance

المؤلفون: Agostina Nardone, Rachel Schiff, Henry Brown, Meghana V. Trivedi, Martin Shea, Mark Pilling, Jamunarani Veeraraghavan, Chandandeep Nagi, Rinath Jeselsohn, Carmine De Angelis, Oona Delpuech, Maria Letizia Cataldo, Tamika Mitchell, C. Kent Osborne, Mothaffar F. Rimawi, Hazel M. Weir, Gary C. Chamness, Xiaoyong Fu, Susan G. Hilsenbeck

المساهمون: Pilling, Mark [0000-0002-7446-6597], Apollo - University of Cambridge Repository, Nardone, A., Weir, H., Delpuech, O., Brown, H., De Angelis, C., Cataldo, M. L., Fu, X., Shea, M. J., Mitchell, T., Veeraraghavan, J., Nagi, C., Pilling, M., Rimawi, M. F., Trivedi, M., Hilsenbeck, S. G., Chamness, G. C., Jeselsohn, R., Osborne, C. K., Schiff, R.

المصدر: British Journal of Cancer

مصطلحات موضوعية: Cancer Research, Indoles, Neoplasms, Hormone-Dependent, Breast Neoplasms, Article, 03 medical and health sciences, chemistry.chemical_compound, Mice, MCF-7 Cell, 0302 clinical medicine, Breast cancer, Cinnamate, In vivo, medicine, Animals, Humans, Receptor, skin and connective tissue diseases, Fulvestrant, Cancer, Cell Proliferation, Estradiol, Animal, Cell growth, Estrogens, medicine.disease, Estrogen, Metastatic breast cancer, 3. Good health, Tamoxifen, Oncology, chemistry, Receptors, Estrogen, Indole, Cell culture, Cinnamates, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, MCF-7 Cells, Heterografts, Female, Growth inhibition, Heterograft, Breast Neoplasm, Human, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1307add3c66d5075ec69b579adb4aedTest
http://europepmc.org/articles/PMC6353941Test

4

GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

المساهمون: Caraglia M., Correale P., Giannicola R., Staropoli N., Botta C., Pastina P., Nesci A., Caporlingua N., Francini E., Ridolfi L., Mini E., Roviello G., Ciliberto D., Agostino R.M., Strangio A., Azzarello D., Nardone V., Falzea A., Cappabianca S., Bocchetti M., D'Arrigo G., Tripepi G., Tassone P., Addeo R., Giordano A., Pirtoli L., Francini G., Tagliaferri P., Caraglia, M., Correale, P., Giannicola, R., Staropoli, N., Botta, C., Pastina, P., Nesci, A., Caporlingua, N., Francini, E., Ridolfi, L., Mini, E., Roviello, G., Ciliberto, D., Agostino, R. M., Strangio, A., Azzarello, D., Nardone, V., Falzea, A., Cappabianca, S., Bocchetti, M., D'Arrigo, G., Tripepi, G., Tassone, P., Addeo, R., Giordano, A., Pirtoli, L., Francini, G., Tagliaferri, P.

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e82d6e24a5976a7a68e0ca6f5ecc12Test
http://hdl.handle.net/10447/513045Test

5

Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma

المؤلفون: Annalisa Nardone, Annarita Fanizzi, Anna Albano, Angela Monica Sciacovelli, Ivana De Risi, Michele Guida, Sabino Strippoli, Giacoma De Tullio, Andrea Armenio, Raffaella Massafra, Antonio Negri, Davide Quaresmini

المصدر: Cells
Volume 10
Issue 2
Cells, Vol 10, Iss 406, p 406 (2021)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Lung Neoplasms, Lymphocyte, T cell, Ipilimumab, Antineoplastic Agents, CD8-Positive T-Lymphocytes, Article, immunotherapy resistance, 03 medical and health sciences, Basal (phylogenetics), 0302 clinical medicine, Immune system, Carcinoma, Non-Small-Cell Lung, medicine, Humans, lcsh:QH301-705.5, double negative T cells, Melanoma, Aged, Aged, 80 and over, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, medicine.disease, Blockade, 030104 developmental biology, medicine.anatomical_structure, lcsh:Biology (General), 030220 oncology & carcinogenesis, Cancer research, Female, Immunotherapy, business, checkpoint inhibitors, CD8, Biomarkers, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838c025a7258e0e0e290f5588f1a19caTest
https://pubmed.ncbi.nlm.nih.gov/33669266Test

6

The role of radiation therapy and systemic therapies in elderly with breast cancer

المؤلفون: Sara Falivene, Cesare Guida, Valerio Nardone, Francesca Maria Giugliano, Matteo Muto, Pasqualina Giordano, Bruno Daniele, Marcella Gaetano

المساهمون: Nardone, Valerio, Falivene, Sara, Giugliano, Francesca Maria, Gaetano, Marcella, Giordano, Pasqualina, Muto, Matteo, Daniele, Bruno, Guida, Cesare

المصدر: Translational Cancer Research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f16a4a569b4332e6abb3bc9c41fe49Test
http://hdl.handle.net/11591/471871Test

7

Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

المساهمون: Giuliano, Mario, Hu, H, Wang, Yc, Fu, X, Nardone, Agostina, Herrera, S, Mao, S, Contreras, A, Gutierrez, C, Wang, T, Hilsenbeck, Sg, DE ANGELIS, Carmine, Wang, Nj, Heiser, Lm, Gray, Jw, Lopez Tarruella, S, Pavlick, Ac, Trivedi, Mv, Chamness, Gc, Chang, Jc, Osborne, Ck, Rimawi, Mf, Schiff, R.

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Time Factors, Antineoplastic Agents, Hormonal, Cell Survival, Receptor, ErbB-2, medicine.medical_treatment, Gene Expression, Estrogen receptor, Breast Neoplasms, Lapatinib, Article, Mice, Downregulation and upregulation, Cell Line, Tumor, Internal medicine, Animals, Humans, Medicine, Molecular Targeted Therapy, Epidermal growth factor receptor, skin and connective tissue diseases, neoplasms, Neoadjuvant therapy, biology, Fulvestrant, business.industry, Cancer, medicine.disease, Xenograft Model Antitumor Assays, Neoadjuvant Therapy, Disease Models, Animal, Endocrinology, Proto-Oncogene Proteins c-bcl-2, Receptors, Estrogen, Oncology, Drug Resistance, Neoplasm, Tumor progression, Quinazolines, Cancer research, biology.protein, Female, Receptors, Progesterone, business, Biomarkers, Signal Transduction, medicine.drug